Retatrutide
Alert me on readoutsComparisons
ComparisonsAOD 9604 peptide vs retatrutide: what the evidence showsAOD 9604 has weak fat-loss evidence and no approval. Retatrutide cut weight 24.2% in trials but also lacks approval. Here's what's actually legal.Read guide →ComparisonsBest peptides for weight loss: where retatrutide actually standsRetatrutide beat placebo by 22 points in a phase 2 trial, but it's not approved or legally compoundable. Here's what the evidence and the law actually say.Read guide →ComparisonsMazdutide vs retatrutide: what the trial data actually showsMazdutide and retatrutide are both unapproved triple/dual agonists in trials. Neither is legally sold in the US. Here's how the data and legal status compare.Read guide →ComparisonsRetatrutide peptide vs GLP-1 drugs: how they actually differRetatrutide hit 24.2% weight loss in trials vs GLP-1 drugs, but it's not FDA-approved and has no lawful compounding path. Here's the real comparison.Read guide →ComparisonsTesamorelin peptide vs retatrutide: what's actually legal and provenTesamorelin is FDA-approved for one narrow use. Retatrutide is not approved at all. Here's the real evidence, dosing data, and legal gap between them.Read guide →